The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic ...

REVEAL GENOMICS, S.L., a biotechnology company advancing precision oncology through biomarker innovation, today announced the ...

Overview of Genomics in Cancer Care MarketThe Global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Gloucester Marine Genomics Institute’s Gloucester Biotechnology Academy celebrated the graduation of its Class of 2025 on ...

Microsoft, Chevron, 10x Genomics, 23andMe, NetApp, NGM Biopharmaceuticals, Pliant Therapeutics and Downtown College Prep have ...

Rising Crime Rates and Demand for Justice: With an increasing population and urbanization, Vietnam has witnessed a rise in criminal activities. This surge in criminal cases has propelled the demand ...

According to the latest study from BCC Research, the "Single-Cell Genomics and Proteomics: Emerging Technologies and Markets" ...

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors ...

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).

A global life sciences and diagnostics group has chosen Bruntwood SciTech’s Alderley Park in Cheshire as its newest UK hub.

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...